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Abstract: Most intracellular proteins are subjected to post-translational modification by ubiquitin.
Accordingly, it is of fundamental importance to investigate the biological and physicochemical
effects of ubiquitylation on substrate proteins. However, preparation of ubiquitylated proteins
by an enzymatic synthesis bears limitations in terms of yield and site-specificity. Recently
established chemical ubiquitylation methodologies can overcome these problems and provide a new
understanding of ubiquitylation. Herein we describe the recent chemical ubiquitylation procedures
with a focus on the effects of ubiquitylation on target proteins revealed by the synthetic approach.
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1. Introduction
Ubiquitin plays key roles in a myriad of cellular events via covalent conjugation to intracellular
proteins. Not only has ATP-dependent protein degradation mediated by ubiquitylation (covalent
modification of a protein with ubiquitin) been revealed, but also its non-proteolytic functions in
immune response and DNA repair [1]. According to the Protein Information Resource [2] and the
PhosphoSite Plus database [3], most eukaryotic intracellular proteins are ubiquitylated at multiple
sites. In some cases, polymeric chains of ubiquitin are formed on substrate proteins. These anchored
polyubiquitin chains can have various linkage types and lengths. In polyubiquitin chains, either the
N-terminal residue (M1) or one of seven internal lysine residues (K6, K11, K27, K29, K33, K48, and
K63) of a given ubiquitin molecule is covalently conjugated to the C-terminus of another ubiquitin
molecule [1]. Polyubiquitin chains of different linkage types adopt characteristic conformations that
are specifically recognized by ubiquitin-binding proteins. By this general mechanism, ubiquitylation
can mediate a wide variety of cellular functions; the position of the ubiquitylation site on a given
substrate protein and the linkage type of the polyubiquitin chains are the critical determinants for the
signal transduction process.
To study the function of ubiquitylation and its effect on target proteins, it is necessary to
prepare sufficient amounts of ubiquitylated proteins. Initially, the fusion expression method had
been established to mimic ubiquitylation [4]. In this approach, an uncleavable ubiquitin moiety
(ubiquitin G76V) is fused to the N-terminus of a target protein, which induces the ubiquitin fusion
degradation (UFD) pathway. The fusion protein is specifically degraded by the proteasome via the
recognition of the conjugated ubiquitin moiety by downstream receptor proteins. In fact, this kind
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of ubiquitylation via the N-terminus has been reported to occur in vivo in some proteins, such as the
myoblast determination protein (MyoD) and the cell-cycle regulator p21 [5], whereas in most cases an
isopeptide bond between a lysine residue on the substrate protein and the C-terminal glycine residue
of ubiquitin is formed. In living cells, ubiquitin conjugation occurs by successive enzymatic reactions
involving ubiquitin-activating (E1), ubiquitin-conjugating (E2), and ubiquitin ligase (E3) enzymes [6,7].
Therefore, in cases where all necessary enzymes are identified and available in sufficient amounts,
the ubiquitylation reaction can be reconstituted in vitro. In addition, it is also possible to obtain
ubiquitylated protein samples using co-expression of ubiquitin, substrate proteins and the E1, E2, and
E3 enzymes in Escherichia coli [8]. However, these enzymatic approaches are not applicable to all cases
and it is difficult to regulate polyubiquitylation activity. For instance, even though mono-ubiquitylated
proteins are required for a given study, polyubiquitylated proteins would also be obtained; therefore,
additional purification steps would be required.
On the other hand, a number of chemical ubiquitylation methods have been reported in the last
decade. Compared to enzymatic methods, the chemical approaches are more adjustable with respect to
the site of ubiquitylation and the length of polyubiquitin chains. In particular, the chemical approaches
present powerful strategies in cases where the E2 and E3 enzymes are not identified or are difficult to
prepare. In this review, we discuss recently-established methods of chemical ubiquitylation focusing
on the effects of ubiquitylation on target proteins achieved by the synthetic approach.
2. Strategies for Chemical Preparation of Ubiquitylated Proteins
Many kinds of synthetic methods have been proposed not only for ubiquitylated proteins, but
also for polyubiquitin chains [9]. We summarize the recently-established biological and chemical
ubiquitylation strategies, in which the chemical forms of donor (distal) ubiquitin and acceptor
molecules are described, along with the character of the linkage as compared with native ubiquitylation
(Table 1). Here, we will briefly review the main concepts; more in-depth discussions on chemical
ubiquitylation methods have been presented elsewhere [10–17].
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Table 1. Established methods to prepare samples of ubiquitylated proteins.
Method Donor Ub Acceptor Difference Reference
Co-expression Ub wt Mind bomb – Keren-Kaplan et al. 2012 [8]
Fusion proteins Ub G76V β-gal N-terminal ubiquitylation Johnson et al. 1995 [4]
Alkene-thiol
reaction/chloroketone-thiol
Ub alkene Ub Cys
Thioether linkage
Valkevich et al. 2012 [18]
Ub Cys allylamine Ub Cys allylamine Trang et al. 2012 [19]
Ub G76C Ub Cys Yin et al. 2000 [20]
Alkyne-azide reaction Ub azide
Polyβ Plk
Triazole linkage
Schneider et al. 2014 [21]
PCNA Plk Eger et al. 2011 [22]
Ub Plk Eger et al. 2010 [23]
Ub alkyne Ub AzF Weikart et al. 2012 [24]
Aminoxy-aldehyde reaction Ub aldehyde Ub aminoxy Oxime linkage Shanmugham et al. 2010 [25]
Disulfide conjugation
Ub C-terminal aminoethanethiol linker
Histone H2B Cys
Disulfide bridge
Chatterjee et al. 2010 [26]; Fierz et al. 2011[27]
PCNA Cys Chen et al. 2010 [28]
α-synuclein Cys Meier et al. 2012 [29]; Abeywardana et al. 2013 [30]
Ub G76C
Ras Cys Baker et al. 2013 [31]
CaM Cys, FABP4 Cys, FKBP12 Cys Morimoto et al. 2016 [32]
Ubhydrazide α-globin Cys Hemantha et al. 2014 [33]




Kumar et al. 2009 [35]; Erlich et al. 2010 [36];
Hejjaoui et al. 2011 [37]; Haj-Yahya et al. 2013 [38];
Shabek et al. 2012 [39]
CaM pyrrolysine analogue Cysteine at residue 76 of ubiquitin Li et al. 2009 [40]
Dvl2 DIX Nε−(t−butyloxycarbonyl)−L−lysine – Madrzak et al. 2015 [41]
Histone H2A Nε−(D−cysteinyl)−L−lysine Alanine at residue 76 of ubiquitin Fierz et al. 2012 [42]
Histone H2B thiol−auxiliary
– Chatterjee et al. 2007[43]; McGinty et al. 2008[44]
Alanine at residue 76 of ubiquitin McGinty et al. 2009 [45]
Peptide γ−thiolysine
–
Yang et al. 2009 [46]
Peptide thiol−auxiliary Weller et al. 2014 [47]
Ub azidonorleucine Yang et al. 2014 [48]
Ub Boc−lysine Castaneda et al. 2011 [49]
Ub γ−thiolysine Yang et al. 2010 [50]
Ub δ/γ−thiolysine Merkx et al. 2013 [51]
Ub δ−thiolysine Kumar et al. 2010 [52]; Kumar et al. 2011 [53];Bavikar et al. 2012 [54]; Virdee et al. 2011 [55]
Ub Nε−(t−butyloxycarbonyl)−L−lysine Virdee et al. 2010 [56]
Ub Cys-Pro-ester Histone H3 Cys Thioether linkage Kawakami et al. 2017 [57]
Ub hydrazide Histone H2B
thiol−auxiliary
– Li et al. 2017 [58]
Ub glycyl−auxiliary Pan et al. 2016 [59]
AzF: p-azidophenylalanine; Cys: cysteine mutants; CaM: calmodulin; DIX: Dishevelled-Axin; Dvl2: Dishevelled segment polarity protein 2; FABP4: fatty acid binding protein 4; FKBP12:
FK506-binding protein; G76C: glycine-to-cysteine mutation at residue 76; ICL: isopeptide chemical ligation; Mdm2: murine double minute 2; NCL: native chemical ligation; PCNA:
proliferating cell nuclear antigen; Plk: pyrrolysine analogue; SUMO: small ubiquitin-related modifier; Ub: ubiquitin; wt: wild type. Each linkage structure of ubiquitylation is shown in
Figure 1.
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2.1. Native Chemical Ligation and Isopeptide Chemical Ligation
In the preparation of ubiquitylated proteins, the main challenge was to establish a strategy for
specific isopeptide bond formation between the lysine residue of a given protein and the C-terminal
glycine residue of ubiquitin. One of the most suitable chemical reactions for the isopeptide bond
formation is a chemoselective reaction termed native chemical ligation (NCL). In 1994, Dawson and
co-workers introduced NCL, in which a selective peptide bond is formed between a given peptide
containing a C-terminal α-thioester group and another peptide containing a cysteine residue [60]. The
specificity of NCL makes it a proper method for ubiquitylation by chemical synthesis. In fact, Chatterjee
and co-workers utilized NCL for chemical ubiquitylation in 2007, which was the first report of a
chemical ubiquitylation method [43]. In this method, a recombinantly-expressed ubiquitin-α-thioester
was ligated to the side chain of a lysine residue of the histone H2B peptide with an auxiliary group.
The photolabile auxiliary group was removed by ultraviolet (UV) irradiation and a traceless native
isopeptide bond between the lysine residue of histone H2B and the C-terminal glycine residue of
ubiquitin was formed. This auxiliary-mediated NCL method requires the auxiliary group to be
conjugated on the lysine residue (achieved by using solid-phase peptide synthesis (SPPS)). Moreover,
protein denaturation by guanidine hydrochloride is also necessary for the ligation between the peptide
and ubiquitin. Therefore, the applicability of this method is limited to intrinsically-disordered proteins,
such as N-terminal fragments of histones and α-synuclein, or the proteins that are easily refolded from
the denatured state.
Li and co-workers introduced a genetic incorporation of a pyrrolysine analogue into a target
protein by using the pyrrolysine tRNA and its synthetase [40]. The advantage of this methodology
is that it does not require protein denaturation for the ligation. However, in this method, the
product contains non-native ubiquitin with a cysteine at residue 76 (ubiquitin G76C). In 2010,
Virdee and co-workers solved this problem by genetic incorporation of the unnatural amino acid
Nε-(t-butyloxycarbonyl)-L-lysine [56]. In this methodology, termed “genetically encoded orthogonal
protection and activated ligation” (GOPAL), the isopeptide bond is formed through Ag+-catalyzed
condensation. Importantly, this method does not involve any steps of protein denaturation and allows
a traceless isopeptide bond to be formed between a target protein and ubiquitin [55].
2.2. Ubiquitin Conjugation via Non-Native Linkages
Scientists also developed other synthetic approaches for the chemical ubiquitylation in which
an isopeptide bond between a target protein and ubiquitin is not utilized. Thioester [18–20],
triazole [21–24], oxime [25], disulfide [26–33], maleimide [34], and pyridazinedione linkages [34]
are used instead of isopeptide bonds. The methods using these non-native linkages are relatively
straightforward and appropriate for the preparation of large amounts of ubiquitylated proteins.
In addition, the non-native isopeptide linkages are not cleaved by deubiquitinating enzymes (DUBs),
which allows the determination of the binding affinity of DUBs for the synthesized polyubiquitin
chains [25]. However, the limitations of these non-native linkages are that their chemical properties
(linkage flexibility, length, or bulkiness) are different from those of the native isopeptide linkage
(Figure 1). When investigating direct physicochemical effects of ubiquitylation on target proteins, it is
highly important to consider such differences in chemical composition.
One of the most popular non-native linkage conjugations is disulfide conjugation. In this method,
it is necessary to mutate the lysine residue to be ubiquitylated to a cysteine residue in a target protein.
In addition, one must replace its solvent-exposed intrinsic cysteine residues by mutation to other
amino acids. The disulfide bridge is formed between the C-terminal thiol group of ubiquitin G76C
and the newly-introduced thiol group on the target protein. Importantly, this methodology does not
involve any protein denaturation steps and is a simple, straightforward, and versatile approach. In fact,
the disulfide-mediated ubiquitylation has been applied to many kinds of folded proteins (Table 1).
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Figure 1. Differences in linkage structure between native and chemical ubiquitylation. Since there
is variation in the reported chemical ubiquitylation methods using thioether, triazole, and disulfide
linkages, representative structures are shown as follows: thioether linkage: Valkevich et al. 2012 [18];
triazole linkage is Eger et al. 2011 [22]; disulfide linkage: Chen et al. 2010 [28].
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3. Biological Effects of Ubiquitylation on Substrates
3.1. Recognition of Ubiquitin Tags
The attached ubiquitin moieties on a substrate protein can be recognized by ubiquitin-binding
proteins [61] (Figure 2). Similar to the UFD pathway, chemical ubiquitylation also functions as a
degradation signal via recognition of the attached ubiquitin molecules. Indeed, ubiquitylation-induced
proteasomal degradation of cyclin B [21], α-globin [33], and α-synuclein [39] has been observed.
In general, (poly-)ubiquitin tagged proteins are recruited to the 26S proteasome via recognition of the
ubiquitin tags and degraded in the proteasomal core. In many cases, K48-linked polyubiquitylation
mediates ATP-dependent proteasomal protein degradation [62]. The proteasomal degradation of
α-globin in vitro has clearly indicated that mono-ubiquitylation is not sufficient as a proteolytic
signal and that K48-linked polyubiquitylation induces the proteasomal degradation [33]. On the
other hand, in some cases, other linkage-type polyubiquitin chains appear to regulate protein
degradation. Schneider and co-workers revealed that the addition of chemically-synthesized
K11-linked polyubiquitin chains into extracts of Xenopus eggs prevented degradation of cyclin B.
In addition, they indicated that the treatment with the K11-linked polyubiquitin chains perpetuated
the meiotic state, which is consistent with the fact that K11-linked polyubiquitylation is involved in
cell cycle regulation via protein degradation [63].Int. J. Mo . Sci. 2017, 18, 1145 7 of 13 
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A chemical ubiquitylation study by Shabek and co-workers revealed that mono-ubiquitylation
induces proteasomal degradation of a poly-peptide of ~150 residues without additional
ubiquitylation [39]. As discussed above, in many cases, polyubiquitylation seems to be necessary
for proteasomal degradation. However, mono-ubiquitylation is sufficient for the proteasomal
degradation in the cases of moderately sized proteins (~150 residues); in addition, the conjugated
peptide is also required to be longer than 20 residues [39,64]. A single ubiquitin moiety is sufficient
to target such moderately-sized substrate proteins to the proteasome; on the other hand, in the
cases of larger proteins, longer polyubiquitin chains may be necessary for proteasomal targeting.
Therefore, in the ubiquitin-proteasome pathway, long polyubiquitin chains are not always necessary
to initiate degradation. The size of the substrate proteins may be one of the determinants for
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ubiquitylation-mediated protein degradation. Although it might be difficult to evaluate such
mono-ubiquitylation-driven proteasomal degradation by using enzymatic approaches, the chemical
synthetic method clearly revealed the recognition of the attached mono-ubiquitin for degradation and
the size-regulation in the proteasomal degradation system.
3.2. Generation of New Protein-Protein Interactions
Some of the ubiquitin attachments to target proteins lead to new protein-protein interactions that
are unrelated with protein degradation (Figure 2). The chemical mono-ubiquitylation of proliferating
cell nuclear antigen (PCNA) enhances the interaction with DNA polymerase η (polη), causing a
decrease in DNA synthesis [22,28]. Although the biological role of this mono-ubiquitylation of
PCNA had been well studied before [65,66], the chemical ubiquitylation allowed to investigate
mono-ubiquitylation of PCNA at various positions [28]. The conformation of the attached ubiquitin
moiety appeared to be flexible and, therefore, the mono-ubiquitylation of PCNA at any site observed
appeared to decrease the rate of DNA synthesis. The results suggested that the conformational
flexibility of ubiquitin enables the mediation of a long-range protein-protein interaction among
ubiquitin, PCNA, and polη.
Similar to mono-ubiquitylation of PCNA, histone H2B increased the interaction with the H3K79
methyltransferase hDot1L [26,44,45] and mouse nucleosome assembly protein 1 (mNap1) [42].
The chemical ubiquitylation method allowed sample preparation in high amounts, resulting in
reconstitution of a nucleosome containing ubiquitylated histones. Intriguingly, the stability analysis of
the ubiquitylated nucleosome indicated that ubiquitylation of the H2A–H2B dimer destabilized the
nucleosome due to the increased affinity for mNap1 [42]. The interaction of ubiquitylated H2A–H2B
with mNap1 may disturb the interactions necessary for nucleosome formation: H2A–H2B:(H3–H4)2 or
H2A–H2B:DNA interactions.
3.3. Inhibition of Protein-Protein Interactions
In contrast to ubiquitylation-induced protein-protein interactions, ubiquitylation may inhibit
native protein-protein interactions of the conjugated protein (Figure 2). In the cases of calmodulin [40],
human Dishevelled segment polarity protein 2 (Dvl2) Dishevelled-Axin (DIX) domain [41],
and Ras [31], ubiquitin obstructs the interface on the modified proteins with other proteins.
In particular, Madrzak and co-workers observed that mono-ubiquitylation attenuates the formation
of filament assembly of the DIX domain [41]. The DIX domain has a tendency of head-to-tail
homo(hetero)-polymerization [67]. However, the crystal structure of the DIX domain indicated that
the two ubiquitylation sites (K54 and K58) are located within the DIX tail region, suggesting that
ubiquitylation blocked the DIX–DIX interface. Indeed, the authors experimentally observed that the
DIX filament assembly was severely inhibited by ubiquitylation.
In addition to such a “blocking” effect on a protein due to attached ubiquitin molecules,
ubiquitylation could create steric clashes in a protein complex. In formation of a nucleosome,
ubiquitylation may indeed exert structural influences on histone H2B [58]. The cryo-electron
microscopy structure of the reconstituted nucleosome containing ubiquitylated H2B indicated
that the two flexible ubiquitin moieties protruded in between nucleosome-wrapping DNA chains.
In addition, a thermal stability assay showed that the peak corresponding to the H2A-H2B form of
the nucleosome was shifted toward a slightly lower temperature, suggesting that the nucleosome
containing ubiquitylated H2B was destabilized. Thus, the attached ubiquitin moieties may disturb the
structural properties of the conjugated protein and thereby affect protein-protein interactions.
Int. J. Mol. Sci. 2017, 18, 1145 8 of 13
4. Physicochemical Effects of Ubiquitylation on Target Proteins
4.1. Changes in Aggregation Propensity
Studies that employ chemical ubiquitylation have examined not only biological effects,
but also physicochemical effects of ubiquitylation. Ubiquitin has an extraordinary structural
rigidity and high solubility in vitro. Therefore, it appears that ubiquitylation has the potential
to affect the physicochemical properties of conjugated proteins (Figure 2). Indeed, it has been
shown that mono-ubiquitylation inhibits fibril formation of α-synuclein [29,37], but promotes its
oligomerization [29]. Meier and co-workers investigated the oligomerization and fibril formation
properties of α-synuclein chemically mono-ubiquitylated at various positions using dot blotting and
a Thioflavin-T fluorescence assay, respectively [29]. Fibril formation was inhibited in many of the
mono-ubiquitin modifications (ubiquitylation at K6, K12, K21, K32, K34, K43, and K96); however, some
ubiquitylation sites (ubiquitylation at K10 and K23) resulted in fibril formation levels comparable to
wild-type α-synuclein, thereby highlighting the importance of the site of ubiquitylation in affecting
aggregation. Interestingly, ubiquitylation ofα-synuclein at K96 promoted oligomerization, but not fibril
formation. Thus, ubiquitylation ofα-synuclein has a site-specific profile in terms of oligomerization and
aggregate formation. Importantly, these site-specific mechanistic insights were greatly facilitated by
the chemical approach to ubiquitylation that allowed the generation of protein samples ubiquitylated
at different sites in large quantities.
Unlike mono-ubiquitylation, polyubiquitylation ofα-synuclein was reported to enhance aggregate
formation [38] (Figure 2). Lewy bodies in Parkinson’s disease patients are well known to
contain insoluble aggregates of polyubiquitylated α-synuclein [68,69]. To understand the role of
polyubiquitin in Lewy body formation, Haj-Yahya and co-workers investigated the aggregation
profile of tetra-ubiquitylated α-synuclein using chemical ubiquitylation [38]. After incubation
at 37 ◦C with shaking, unmodified α-synuclein remained soluble for 48 h, whereas K48-linked
tetra-ubiquitylated α-synuclein rapidly formed soluble, but sodium dodecyl sulfate (SDS)-resistant,
aggregates. In addition, wild-type α-synuclein formed mature amyloid fibrils by shaking; in
stark contrast, tetra-ubiquitylated α-synuclein formed amorphous aggregates that did not have the
morphology of amyloid fibrils. Thus, ubiquitylation largely affects the aggregation propensity of
α-synuclein. Intriguingly, this effect strongly depends on the length of the ubiquitin chain and the site
of ubiquitylation.
4.2. Fold Destabilization and Structural Fluctuation
The molecular weight of ubiquitin (8.6 kDa) is considerably higher than that of other typical
post-translational modifiers, such as acetyl (43 Da), methyl (15 Da), and phosphate (97 Da) groups.
Therefore, in addition to the ubiquitylation-induced effects on the solubility and aggregation propensity
discussed above, ubiquitylation may also exert another influence on the physical properties of
target proteins. In fact, a recent molecular dynamics study by Hagai and co-workers indicated
that ubiquitylation may induce partial unfolding of target proteins [70]. For this reason, our group has
experimentally investigated whether ubiquitylation affects thermodynamic stability and structural
dynamics of the modified proteins [32] (Figure 2). After employing disulfide-mediated ubiquitylation
to prepare ubiquitylated proteins, tryptophan fluorescence analysis indicated that the thermal
transition temperatures of calmodulin, fatty acid binding protein 4 (FABP4), and FK506-binding
protein (FKBP12) were decreased by mono-ubiquitylation. Intriguingly, the ubiquitylation-induced
fold destabilization depended on the site at which the ubiquitin moiety was attached. Ubiquitylation of
a residue located in a β-sheet resulted in larger fold destabilization than ubiquitylation of a loop residue;
by contrast, ubiquitylation of a residue located in an α-helix had no significant effect on fold stability.
Thus, covalent conjugation of a ubiquitin moiety to the target proteins decreased the fold stability of
the target protein and the degree of this destabilization depended on the site of ubiquitylation.
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Furthermore, our group detected changes in the structural dynamics of proteins due to
ubiquitylation. Based on the chemical shift analysis of peaks in the 1H–15N hetero-nuclear single
quantum coherence spectra, the average tertiary structures of the ubiquitylated proteins were not
significantly affected. On the other hand, derivation of the spectral density functions in conjunction
with 15N relaxation dispersion experiments indicated that ubiquitylation exerted an influence on
the motion of the conjugated proteins on the millisecond timescale [32]. These data suggest that the
increase in structural fluctuations may explain the lower fold stability of the ubiquitylated protein.
5. Conclusions
Today, it is well-known that ubiquitylation regulates the lifetime, enzymatic activity, and
localization of proteins. Almost all intracellular proteins are subjected to ubiquitylation and a high
number of specific E3 ligases are thought to mediate ubiquitylation. Mass spectroscopic studies have
identified more and more ubiquitylation sites of proteins. However, the connection of E3 ligases to
their target substrate proteins is not yet sufficiently established. Therefore, chemical ubiquitylation is a
powerful and invaluable tool for the preparation of large amounts of ubiquitylated protein samples.
As discussed above, diverse chemical approaches have been proposed, which will help to establish
a comprehensive understanding of the biological and physicochemical properties of ubiquitylation.
In addition, new aspects of ubiquitylation are being continuously uncovered. One of them is the finding
of branched polyubiquitin chains [71–73]. Ubiquitylation appears to be a much more complicated
signal system than expected, compared to when ubiquitin-mediated ATP-dependent proteolysis was
first discovered approximately 40 years ago [74]. The established protocols for chemical ubiquitylation
will accelerate biological and physicochemical studies of ubiquitylation and we anticipate further
development of even more versatile methods of chemical ubiquitylation.
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